Company Filing History:
Years Active: 1989-1992
Title: The Innovations of Hurley D. King
Introduction
Hurley D. King is a notable inventor based in Yardley, Pennsylvania. He holds two patents that showcase his contributions to the fields of medicine and therapeutic agents. His innovative work focuses primarily on the development of conjugates that enhance therapeutic treatments.
Latest Patents
One of Hurley’s latest patents is related to amine-containing porphyrin derivatives. This invention details how these porphyrins can be utilized as photosensitizers that serve as effective therapeutic agents. Furthermore, it describes methods for preparing conjugates where a porphyrin derivative is covalently attached to an antibody or an antibody fragment, paving the way for advanced in vivo therapeutic applications.
The second patent concerns antibody-therapeutic agent conjugates. This invention details the coupling of therapeutic agents to antibodies or antibody fragments and outlines the methods for preparing these conjugates. Hurley’s work in this area aims to enhance therapeutic treatments through innovative in vivo methods that incorporate these conjugates.
Career Highlights
Hurley D. King is associated with Cytogen Corporation, where he employs his research to develop cutting-edge solutions in therapeutic applications. His role in the organization allows him to focus on creating impactful innovations that have the potential to transform medical treatments.
Collaborations
During his career, Hurley has collaborated with fellow researchers and professionals including John W. Goers and Chyi Lee. These partnerships have further enriched the development of his innovative patents, enabling the combination of expertise to push the boundaries of conventional therapies.
Conclusion
Hurley D. King’s inventions reflect a commitment to advancing therapeutic methodologies through innovative scientific research. His patents not only demonstrate his creativity but also his dedication to enhancing medical treatments, making significant contributions to the field.